← Back to Search

Behavioural Intervention

Music Therapy for Dementia (MCTM Trial)

N/A
Waitlist Available
Research Sponsored by The Hearthstone Institute, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Volunteers must be aged 55+ and speak/read conversational English.
Staff participants must be at least 18 years old, work within a residential care facility participating in the study, and speak and read English.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (weeks 1-4) treatment (weeks 5-12)
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to utilize retired volunteers to facilitate interventions for people with dementia, with the goal of improving engagement, quality of life, and reducing behavioral expressions.

Who is the study for?
This trial is for volunteers aged 55+ and staff at residential care facilities, both groups must speak/read English. Residents with dementia eligible for the study must be diagnosed with any type of dementia, score 10+ on MMSE, be aged 65+, and speak/read English. Those showing rapid decline or working third shift only are excluded.
What is being tested?
The trial tests 'Making Connections Thru Music' (MCTM), a program where retired volunteers facilitate music-based interventions to improve engagement and quality of life in people with dementia. It includes an online training course for volunteers and an app containing the intervention protocol.
What are the potential side effects?
Since this is a non-medical intervention focusing on music and discussion, traditional side effects associated with medications are not expected. However, individual responses to social interaction can vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 55 years old or older and can speak and read English.
Select...
I am over 18, work in a care facility in the study, and speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (weeks 1-4) treatment (weeks 5-12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (weeks 1-4) treatment (weeks 5-12) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Menorah Park Engagement Scale
Secondary study objectives
Alzheimer's Disease Knowledge Scale
Geriatric Depression Scale- Short Form. Scores can range from zero to 15. Higher scores suggest a worse outcome
Neuropsychiatric Inventory - Nursing Home.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MCTM InterventionExperimental Treatment1 Intervention
Activity sessions will be led by activity volunteers
Group II: ControlActive Control1 Intervention
Activity sessions will be led by activity professionals

Find a Location

Who is running the clinical trial?

The Hearthstone Institute, LLCLead Sponsor
4 Previous Clinical Trials
290 Total Patients Enrolled
Hopeful AgingLead Sponsor
5 Previous Clinical Trials
410 Total Patients Enrolled
Benjamin Rose Institute on AgingOTHER
4 Previous Clinical Trials
2,396 Total Patients Enrolled
~131 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top